Market Overview:
The global Sjogren's Syndrome therapeutics market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of Sjogren's Syndrome, rising awareness about the disease, and technological advancements in the field of diagnostics and therapeutics. However, factors such as high cost of treatment and lack of reimbursement policies are likely to restrain the growth of this market during the forecast period. The global Sjogren's Syndrome therapeutics market can be segmented on the basis of type into primary and secondary Sjogren's Syndrome. The primary form is more common than secondary form and accounts for more than 90% cases worldwide. On the basis of application, this market can be segmented into clinical applications and hospital applications. Clinical applications include diagnosis (e.g., salivary gland biopsy) and treatment (e.g., rituximab). Hospital applications include use in intensive care units (ICUs), operating theaters, wards etc.
Product Definition:
Sjogren's Syndrome Therapeutics is a branch of medicine that deals with the treatment of Sjogren's Syndrome. It is important because it can help improve the quality of life for people who suffer from Sjogren's Syndrome.
Primary:
The primary antibodies are the first line of defense against pathogens. They are responsible for initiating the inflammatory response by attaching themselves to molecules in the pathogen. The more antibodies there are, the stronger is this immune response and thus, it leads to disease progression. In sjogren's syndrome, an excess of these autoantibodies is produced due to a defect in antibody-related genes that encodes for B cell-specific transcription factors (BRF).
Secondary:
The secondary antibody is used in the treatment of sjogren's syndrome. It works by binding to any antigens that are present on the cells or tissues and helps in destruction of these cells or tissues. The antibodies produced by the body during sjogren’s syndrome attacks certain body functions such as it affects different organs, joints, and skin colors along with causing severe pain in hands, feet, legs & stomach area.
Application Insights:
The clinical application segment held the largest share of 60.0% in 2017. The growing prevalence of chronic conditions, such as diabetes and autoimmune diseases, is expected to contribute to the growth of this segment over the forecast period. Sjogren¢â‚¬â„¢s syndrome occurs more frequently in women than in men; hence, it is considered as a female reproductive disorder and affects mostly women aged 30-50 years.
According to estimates reported by WHO, around 1:4000 females above 40 years old are affected with sjogren¢â‚¬â„¢s syndrome globally every year since 2015.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement scenario and increasing prevalence of autoimmune diseases are some factors responsible for its growth. In addition, growing awareness about Sjogren’s syndrome among patients is expected to drive the region during the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period owing to rising healthcare expenditure by governments and private organizations as well as an increase in awareness about chronic diseases such as rheumatoid arthritis or lupus erythematosus that affect mostly women are driving this growth.
Key players operating in this industry include Actavis plc; Allergan Plc; Pfizer Inc.; F. Hoffmann-La Roche AG; Merck & Co., Inc.
Growth Factors:
- Increasing incidence of Sjogren's Syndrome
- Growing awareness about Sjogren's Syndrome
- Rising demand for better treatment options for Sjogren's Syndrome
- Technological advancements in the field of Sjogren's Syndrome therapeutics
- Availability of government funding for research and development in the field of Sjogren's Syndrome therapeutics
Scope Of The Report
Report Attributes
Report Details
Report Title
Sjogren's Syndrome Therapeutics Market Research Report
By Type
Primary, Secondary
By Application
Clinical, Hospital
By Companies
Allergan, Biogen, Bristol-Myers Squibb, F. Hoffmann-La Roche, Novartis, Kissei Pharmaceutical, Aldeyra Therapeutics, GlaxoSmithKline, Biogen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
125
Number of Tables & Figures
88
Customization Available
Yes, the report can be customized as per your need.
Global Sjogren's Syndrome Therapeutics Market Report Segments:
The global Sjogren's Syndrome Therapeutics market is segmented on the basis of:
Types
Primary, Secondary
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical, Hospital
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan
- Biogen
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- Novartis
- Kissei Pharmaceutical
- Aldeyra Therapeutics
- GlaxoSmithKline
- Biogen
Highlights of The Sjogren's Syndrome Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Primary
- Secondary
- By Application:
- Clinical
- Hospital
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sjogren's Syndrome Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sjogren's Syndrome Therapeutics is a biotechnology company focused on the development of novel therapeutics for patients with Sjogren's syndrome. The company has developed two products, SB-728 and SB-928, which are currently in Phase III clinical trials.
Some of the major companies in the sjogren's syndrome therapeutics market are Allergan, Biogen, Bristol-Myers Squibb, F. Hoffmann-La Roche, Novartis, Kissei Pharmaceutical, Aldeyra Therapeutics, GlaxoSmithKline, Biogen.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sjogren's Syndrome Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sjogren's Syndrome Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sjogren's Syndrome Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sjogren's Syndrome Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sjogren's Syndrome Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Sjogren's Syndrome Therapeutics Market Size and Y-o-Y Growth
4.5.2 Sjogren's Syndrome Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Sjogren's Syndrome Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Sjogren's Syndrome Therapeutics Market Size Forecast by Type
5.2.1 Primary
5.2.2 Secondary
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Sjogren's Syndrome Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Sjogren's Syndrome Therapeutics Market Size Forecast by Applications
6.2.1 Clinical
6.2.2 Hospital
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sjogren's Syndrome Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sjogren's Syndrome Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Sjogren's Syndrome Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Sjogren's Syndrome Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Sjogren's Syndrome Therapeutics Market Size Forecast by Type
9.6.1 Primary
9.6.2 Secondary
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Sjogren's Syndrome Therapeutics Market Size Forecast by Applications
9.10.1 Clinical
9.10.2 Hospital
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Sjogren's Syndrome Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Sjogren's Syndrome Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Sjogren's Syndrome Therapeutics Market Size Forecast by Type
10.6.1 Primary
10.6.2 Secondary
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Sjogren's Syndrome Therapeutics Market Size Forecast by Applications
10.10.1 Clinical
10.10.2 Hospital
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Sjogren's Syndrome Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Sjogren's Syndrome Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Sjogren's Syndrome Therapeutics Market Size Forecast by Type
11.6.1 Primary
11.6.2 Secondary
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Sjogren's Syndrome Therapeutics Market Size Forecast by Applications
11.10.1 Clinical
11.10.2 Hospital
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Sjogren's Syndrome Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Sjogren's Syndrome Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Sjogren's Syndrome Therapeutics Market Size Forecast by Type
12.6.1 Primary
12.6.2 Secondary
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Sjogren's Syndrome Therapeutics Market Size Forecast by Applications
12.10.1 Clinical
12.10.2 Hospital
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Sjogren's Syndrome Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Sjogren's Syndrome Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Sjogren's Syndrome Therapeutics Market Size Forecast by Type
13.6.1 Primary
13.6.2 Secondary
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Sjogren's Syndrome Therapeutics Market Size Forecast by Applications
13.10.1 Clinical
13.10.2 Hospital
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sjogren's Syndrome Therapeutics Market: Competitive Dashboard
14.2 Global Sjogren's Syndrome Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Allergan
14.3.2 Biogen
14.3.3 Bristol-Myers Squibb
14.3.4 F. Hoffmann-La Roche
14.3.5 Novartis
14.3.6 Kissei Pharmaceutical
14.3.7 Aldeyra Therapeutics
14.3.8 GlaxoSmithKline
14.3.9 Biogen
